Oncology Group of Southern Italy

Recent publications and citations

Top Concepts

Top subject area publications in last 5 years

Collaboration Analysis

Publications from 2021 to 2026

Latest Publications

Filter IconFilter

Showing 7 of 7 papers

  • Research Article
  • Citations21

Active notch protects MAPK activated melanoma cell lines from MEK inhibitor cobimetinib

  • Nov 14, 2020
  • Biomedicine & Pharmacotherapy
  • Letizia Porcelli +7
  • Open Access
  • Abstract

186O - Tumor-infiltrating lymphocytes (TILs) as an independent prognostic factor for early HER2+ breast cancer patients treated with adjuvant chemotherapy and trastuzumab in the randomized shortHER trial

  • Oct 01, 2018
  • Annals of Oncology
  • M.v Dieci +19
  • Open Access
  • Research Article
  • Citations60

Cisplatin/Pemetrexed Followed by Maintenance Pemetrexed Versus Carboplatin/Paclitaxel/Bevacizumab Followed by Maintenance Bevacizumab in Advanced Nonsquamous Lung Cancer: The GOIM (Gruppo Oncologico Italia Meridionale) ERACLE Phase III Randomized Trial

  • Dec 09, 2014
  • Clinical Lung Cancer
  • Domenico Galetta +15
  • Research Article

Moderately high-dose carboplatin with paclitaxel and intraperitoneal cisplatin improves progression-free survival but has higher toxicity than standard intravenous cisplatin and paclitaxel for small volume ovarian cancer

  • Dec 01, 2001
  • Evidence-based Oncology
  • Mario De Lena
  • Research Article
  • Citations88

Phase I/II study of gemcitabine plus vinorelbine as first-line chemotherapy of non-small-cell lung cancer.

  • Jan 01, 2000
  • Journal of Clinical Oncology
  • Vito Lorusso +11
  • Research Article
  • Citations14

Double biochemical modulation of 5-fluorouracil by methotrexate and levo-folinic acid in the treatment of advanced digestive tract malignancies.

  • Sep 01, 1996
  • European Journal of Cancer
  • P Comella +10
  • Abstract

477 Chemo-immunotherapy of metastatic renal cell cancer (MRCC) with subcutaneous low doses of re-combinant interleukin 2 (IL2) and 4-epirubicin (EPI)

  • Nov 01, 1995
  • European Journal of Cancer
  • G Colucci +7
Cactus Communications logo

Copyright 2026 Cactus Communications. All rights reserved.